Abstract
In concern of cervical cancer through the various screening and health care programmes running in Asian and Western countries, it was established that the prevalence and mortality has declined tremendously. However cervical cancer is still considered as one of the fetal and common cancer in females, followed by breast cancer and lung cancer in India. In the present study, blood samples of confirmed cervical cancer patients through biopsy examination were collected and subjected for genomic DNA isolation. Isolated DNA samples were amplified for detection of NAT-2 gene, subsequently gene polymorphism was detected using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. We observed that NAT-2 gene polymorphism was significantly associated with cervical cancer risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
